Africa records lowest meningitis cases

2013-06-07 07:48


Multimedia   ·   User Galleries   ·   News in Pictures Send us your pictures  ·  Send us your stories

London - Case numbers in Africa's meningitis season this year were the lowest in 10 years thanks to a cheap new vaccine designed to treat a type of the disease common in the so-called meningitis belt, the World Health Organisation said on Thursday.

The vaccine, called MenAfriVac, was developed with funding from the Bill & Melinda Gates Foundation specifically for use against meningitis A, a type which causes regular epidemics in Africa.

Detailing data for January 1 to May 12, the United Nations health agency said that just under 9 250 meningitis cases, including 857 deaths, were reported in 18 of the 19 African countries under enhanced surveillance for meningitis.

Epidemics of meningitis A occur regularly in Africa's "meningitis belt", a band of 26 countries stretching from Senegal to Ethiopia, and are particularly devastating to children and young adults.

Bacterial meningitis, known as meningococcal meningitis, is a serious infection of the thin lining surrounding the brain and spinal cord. It can cause severe brain damage and is fatal in 50% of cases if untreated.

According to the non-profit Meningitis Vaccine Project (MVP), which helped develop the MenAfriVac vaccine, the seasonal outbreak of meningitis across sub-Saharan Africa in 2009 infected at least 88 000 people and killed more than 5 000.

The WHO said the falling numbers this year were due to the introduction of the newly developed vaccine. MenAfriVac costs just 50c a dose and has been progressively introduced in Africa since 2010, starting in Burkina Faso, Mali and Niger.

"The introduction of this first meningococcal vaccine available for preventive purposes in Africa has enabled the immunisation of over 100 million people from 10 countries in the meningitis belt in the past three years," the WHO said.

"The reduced case load and epidemic activity observed this year adds to the evidence on the impact...of this vaccine."

Read more on:    un  |  world health organisation  |  meningitis  |  africa  |  health

Join the conversation! encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions. publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Inside News24


Book flights

Compare, Book, Fly

Traffic Alerts
There are new stories on the homepage. Click here to see them.


Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire network.


Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.